Physician profile
Henry Oneal
NPI 1700074432
$1,673.17
in general payments reported to CMS, 2019-2025
18 companies · $602 in 2025
The $602 reported for 2025 was more than what 77% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $327 · 2020: $35.65 · 2021: $177 · 2022: $231 · 2023: $201 · 2024: $99.19 · 2025: $602.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $902.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $902.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $266.64 | 2021-2025 | Freestyle Libre 3, Freestyle Libre 2 |
| Janssen Pharmaceuticals, INC | $203.36 | 2019-2023 | Xarelto |
| Dexcom, INC. | $187.04 | 2021-2025 | Dexcom G6 Transmitter |
| Bayer Healthcare Pharmaceuticals INC. | $173.94 | 2025 | |
| Xeris Pharmaceuticals, INC. | $132.69 | 2022-2023 | Gvoke Hypopen |
| Sanofi-Aventis U.S. LLC | $117.68 | 2025 | |
| Novartis Pharmaceuticals Corporation | $94.77 | 2019-2021 | |
| Astrazeneca Pharmaceuticals LP | $83.16 | 2025 | Airsupra |
| Pfizer INC. | $75.57 | 2019 | |
| Gilead Sciences, INC. | $70.55 | 2019 | |
| Emergent Biosolutions INC. | $56.96 | 2019 | |
| Evoke Pharma, INC. | $44.01 | 2021-2025 | |
| Novo Nordisk INC | $42.53 | 2019-2024 | Ozempic, Rybelsus |
| Lilly USA, LLC | $36.05 | 2022 | |
| Abbvie INC. | $30.41 | 2025 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $20.90 | 2024 | Krystexxa |
| Exact Sciences Corporation | $20.88 | 2023 | Cologuard Collection Kit |
| Corcept Therapeutics | $16.03 | 2025 | Korlym |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Henry Oneal listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.